Multi-omics characterization and therapeutic liability of ferroptosis in melanoma

被引:13
|
作者
He, Yi [1 ]
Dong, Yu [2 ]
Chen, Yong [3 ,4 ]
Zhang, Guanxiong [1 ]
Zhang, Hailun [5 ]
Lei, Guang [6 ,7 ]
Du, Yanhua [2 ]
Chen, Xiang [1 ]
Ye, Youqiong [2 ]
Liu, Hong [1 ]
机构
[1] Cent South Univ, Xiangya Clin Res Ctr Canc Immunotherapy, Hunan Key Lab Skin Canc & Psoriasis,Dept Dermatol, Hunan Engn Res Ctr Skin Hlth & Dis,Xiangya Hosp, Changsha, Peoples R China
[2] Shanghai Jiao Tong Univ, Sch Med, Dept Immunol & Microbiol, Shanghai Inst Immunol, Shanghai, Peoples R China
[3] Fudan Univ, Shanghai Canc Ctr, Dept Musculoskeletal Surg, Shanghai, Peoples R China
[4] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China
[5] Beijing GAP Biotechnol Co Ltd, Dept Res & Dev, Beijing, Peoples R China
[6] Cent South Univ, Hunan Canc Hosp, Dept Radiat Oncol, Changsha, Peoples R China
[7] Cent South Univ, Affiliated Canc Hosp, Xiangya Sch Med, Changsha, Peoples R China
基金
中国博士后科学基金; 中国国家自然科学基金;
关键词
D O I
10.1038/s41392-022-01067-y
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页数:4
相关论文
共 50 条
  • [1] Multi-omics characterization and therapeutic liability of ferroptosis in melanoma
    Yi He
    Yu Dong
    Yong Chen
    Guanxiong Zhang
    Hailun Zhang
    Guang Lei
    Yanhua Du
    Xiang Chen
    Youqiong Ye
    Hong Liu
    [J]. Signal Transduction and Targeted Therapy, 7
  • [2] A multi-omics study on cutaneous and uveal melanoma
    Zhang, Qi
    Lin, Ze-Nan
    Chen, Jie
    Zheng, Wen-Xu
    [J]. INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2021, 14 (01) : 32 - 41
  • [3] A multi-omics study on cutaneous and uveal melanoma
    Qi Zhang
    Ze-Nan Lin
    Jie Chen
    Wen-Xu Zheng
    [J]. International Journal of Ophthalmology, 2021, 14 (01) : 32 - 41
  • [4] Multi-omics Characterization of Response to PD-1 Inhibitors in Advanced Melanoma
    Trilla-Fuertes, Lucia
    Gamez-Pozo, Angelo
    Prado-Vazquez, Guillermo
    Lopez-Vacas, Rocio
    Soriano, Virtudes
    Garicano, Fernando
    Lecumberri, M. Jose
    de la Borbolla, Maria Rodriguez
    Majem, Margarita
    Perez-Ruiz, Elisabeth
    Gonzalez-Cao, Maria
    Oramas, Juana
    Magdaleno, Alejandra
    Fra, Joaquin
    Martin-Carnicero, Alfonso
    Corral, Monica
    Puertolas, Teresa
    Ramos-Ruiz, Ricardo
    Dittmann, Antje
    Nanni, Paolo
    Vara, Juan Angel Fresno
    Espinosa, Enrique
    [J]. CANCERS, 2023, 15 (17)
  • [5] Multi-omics studies reveal genes critical for AKI and ferroptosis
    Sakashita, Midori
    Nangaku, Masaomi
    [J]. KIDNEY INTERNATIONAL, 2022, 101 (04) : 665 - 667
  • [6] Multi-omics approaches to therapeutic target identification
    Hassan, Md Imtaiyaz
    [J]. BRIEFINGS IN FUNCTIONAL GENOMICS, 2023, 22 (02) : 75 - 75
  • [7] Multi-Omics Reveals IBS Therapeutic Targets
    不详
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 108 (06) : 1121 - 1121
  • [8] Multi-Omics Characteristics of Ferroptosis Associated with Colon Adenocarcinoma Typing and Survival
    Chen, Xiao-Qiong
    Lian, Ke
    Chen, Zi-Wei
    Zhang, Xuan
    Li, Ting
    Wu, Tao
    Shen, Tao
    Cai, Xin-Yi
    Cheng, Xian-Shuo
    Xiao, Fu-Hui
    Li, Yun-Feng
    [J]. FRONTIERS IN BIOSCIENCE-LANDMARK, 2024, 29 (01):
  • [9] Crosstalk of Multi-Omics Platforms with Plants of Therapeutic Importance
    Pandita, Deepu
    Pandita, Anu
    Wani, Shabir Hussain
    Abdelmohsen, Shaimaa A. M.
    Alyousef, Haifa A.
    Abdelbacki, Ashraf M. M.
    Al-Yafrasi, Mohamed A.
    Al-Mana, Fahed A.
    Elansary, Hosam O.
    [J]. CELLS, 2021, 10 (06)
  • [10] Multi-omics characterization of the monkeypox virus infection
    Huang, Yiqi
    Bergant, Valter
    Grass, Vincent
    Emslander, Quirin
    Hamad, M. Sabri
    Hubel, Philipp
    Mergner, Julia
    Piras, Antonio
    Krey, Karsten
    Henrici, Alexander
    Oellinger, Rupert
    Tesfamariam, Yonas M.
    Dalla Rosa, Ilaria
    Bunse, Till
    Sutter, Gerd
    Ebert, Gregor
    Schmidt, Florian I.
    Way, Michael
    Rad, Roland
    Bowie, Andrew G.
    Protzer, Ulrike
    Pichlmair, Andreas
    [J]. NATURE COMMUNICATIONS, 2024, 15 (01)